SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,250,000 | +6.2% | 2,500,000 | +8.7% | 0.43% | -2.0% |
| Q2 2018 | $4,002,000 | +9.3% | 2,300,000 | +15.0% | 0.44% | +2.3% |
| Q1 2018 | $3,660,000 | -13.6% | 2,000,000 | +5.3% | 0.43% | -13.8% |
| Q4 2017 | $4,237,000 | -2.6% | 1,900,000 | +26.7% | 0.50% | -11.0% |
| Q3 2017 | $4,350,000 | +95.5% | 1,500,000 | +200.0% | 0.56% | +87.3% |
| Q2 2017 | $2,225,000 | +218.3% | 500,000 | +233.3% | 0.30% | +203.0% |
| Q1 2017 | $699,000 | – | 150,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |